APF 2024 @ Staburo

APF 2024 @ Staburo

APF 2024 @ Staburo

Staburo GmbH wants to thank everyone who joined the annual APF meeting 2024 on November 29, 2024, in Munich. The event opened with a statement from Staatsministerin Gerlach and Prof. Dr. Anne-Laure Boulesteix, LMU, President of the German Region of the International Biometric Society (IBS-DR), and brought together dedicated experts, researchers, and professionals who shared valuable perspectives on the challenges and innovations surrounding this year’s focus on drug development for rare diseases. Our agenda continued with the talks by our speakers including Dr. Michael Kunz, Dr. Martin Oliver Sailer, Prof. Dr. Franz König, Dr. Tim Friede, Dr. Tobias Bluhmki, and Dr. Katrin Kupas, for sharing their valuable insights and strategies. 

After the lunch break with plenty of refreshments and time to connect, the event continued with updates from the APF working groups and the elections for the new APF board. We are happy to announce that Dr. Frank Langer, Dr. Thomas Bregenzer, Dr. Frank Fleischer, Dr. Cornelia Kunz, Susanne Schäfer, Dr. René Kubiak, and Dr. Jens-Otto Andreas were elected. We would like to thank Prof. Dr. Christoph Gerlinger once again for his dedicated support of the APF since 2009 and hope that he will also be present at the next events! 

The panel discussion at the end with Hans-Juergen Lomp, Prof. Dr. Franz König, Prof. Dr. Tim Friede, Dr. Katrin Kupas, Dr. Tobias Bluhmki, and Dr. Tobias Mielke offered further insights and encouraged collaboration among participants. We were thrilled to see such active engagement, which continued into the informal get-together and beer tasting, where new connections were made and ideas exchanged. 

Thank you once again to our speakers, panelists, and participants for making this workshop a success. Your contributions are driving innovation and helping advance treatments for rare diseases. We look forward to future events and continued collaboration in this important field! 

Data analysis, clinical biostatistics and more.

Staburo presents @ PSI Biomarkers SIG meeting

Staburo presents @ PSI Biomarkers SIG meeting

Staburo presents @ PSI Biomarkers SIG meeting

We are proud to announce that on November 7th, 2024, our director of biostatistics in the focus area biomarkers, Laura Schlieker delivered gave an insightful presentation on “Deep Learning in Image Analysis” at the PSI/EFSPI Biomarkers Special Interest Group (SIG) within the Machine Learning (ML) substream. This prestigious subgroup brings together around 20 experienced statisticians and data scientists from leading pharma companies and the healthcare sector to explore recent advancements in biomarkers research and in particular in the field of machine learning. 

In the presentation, our colleague highlighted the rapidly growing importance of Artificial Intelligence (AI) and Machine Learning in healthcare. Key topics included: 

  • An Introduction to Deep Learning for image analysis, essential for tasks like image classification, segmentation, and object detection. 
  • A deep dive into neural networks, focusing on convolutional neural networks (CNNs) and their applications in healthcare. 
  • A balanced discussion on the benefits and challenges of implementing deep learning for complex image analysis in a healthcare setting. 

This event also offered a valuable forum for exchanging knowledge and experiences with industry experts, underscoring our commitment to pioneering innovative approaches in AI and advancing biomarkers research across sectors. 

For more about the PSI/EFSPI Biomarkers SIG and its impactful work, please visit: PSI/EFSPI Biomarkers SIG. 

Data analysis, clinical biostatistics and more.

Health Day @ Staburo

Health Day @ Staburo

Health Day @ Staburo

At Staburo, health isn’t just a priority—it’s at the heart of everything we do. Our mission to deliver exceptional data science solutions goes hand in hand with our commitment to improving and saving lives, including the well-being of our own team members. We believe a healthy work environment—both physically and mentally—is essential for success.

As part of our ongoing dedication to employee health, we recently hosted our second health day at the Staburo office. The day was filled with engaging presentations and activities centered around mental health, stress management, and resilience. Employees also had the chance to get an eye check.

Additionally, we offered stress type counseling sessions, led by experts from Techniker Krankenkasse, providing personalized advice and strategies for managing stress effectively. To further boost everyone’s health, Kloster Kitchen provided a selection of immune-boosting shots and smoothies for everyone to enjoy.

It was wonderful to see so many colleagues participate in the day’s events, and we would like to extend a big thank you to all employees for their enthusiasm and engagement. A special thanks as well to Techniker Krankenkasse and Kloster Kitchen for their valuable contributions.

We look forward to continuing our efforts in fostering a healthier, happier workplace for all at Staburo.

 

Data analysis, clinical biostatistics and more.

ESG project study

ESG project study

Staburo’s ESG initiative supported by TUM students

We at Staburo GmbH are committed to maintain the highest ethical standards across legal, environmental, and social areas, as outlined in our company’s philosophy.  

Based on the current EU corporate sustainability reporting directive (CSRD) Staburo currently takes a closer look on how our ESG (environmental, social and governance) actions affect our business. We are delighted that our current working student Alkida Hoxhaj and her fellow student Gledis Zhugli from Technical University München (TUM) support Staburo within this field. 

For Alkida and Gledis this is a key part of their academic journey, where they’ll be applying their knowledge and research skills to real-world industry challenges. The project is accompanied by supervisors from TUM and Staburo and will run until the end of the year 2024.  

We already look forward to the results of the project and are convinced that these new insights will further support us in meeting the highest standards in corporate responsibility. 

Data analysis, clinical biostatistics and more.

Staburo @ Wiesn 2024

Staburo @ Wiesn 2024

Staburo @ Wiesn 2024

Just a few days ago, the Staburo annual Wiesn event took place, marking yet another unforgettable Oktoberfest celebration with our team and clients. The Oktoberfest has become a cherished tradition at Staburo, and this year was no exception.

We were fortunate once again to secure enough tables—this time accommodating 70 seats—in the lively Bräurosl tent, where the entire team, along with long-time customers, gathered for an evening of laughter, singing, and dancing. Some of our more adventurous colleagues also took on the exhilarating roller coaster rides, adding to the fun!

With our diverse and ever-growing international team, we were delighted to have even more first-time Oktoberfest visitors join us this year, experiencing the magic of the Wiesn for themselves.

A huge thank you to everyone who helped make the 2024 Wiesn event such a wonderful and fun experience. We’re already looking forward to celebrating again next year!

Data analysis, clinical biostatistics and more.

Safety & Health @ Staburo

Safety & Health @ Staburo

Safety & Health @ Staburo

Workplace safety and health is something we at Staburo take very seriously as part of our employer responsibility. 

That is why we completed a first aiders refresher training together with nine Staburo colleagues a couple of weeks ago.

The first aiders training was an insightful session at the ADAC training center in Munich. It was a hot day, but full of fun and engaging moments, as we practiced various scenarios  We feel well prepared to provide first aid to our colleagues in case of injuries.  

In addition, our health day 2024 will take place soon and will cover safety topics and a wide range of health topics. We are already looking forward to the latest health tips and some healthy activities in the office in October. 

Data analysis, clinical biostatistics and more.